F2RL1 antibody (C-Term)
Quick Overview for F2RL1 antibody (C-Term) (ABIN2788314)
Target
See all F2RL1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- C-Term
- 
                                            Sequence
- VSHDFRDHAK NALLCRSVRT VKQMQVSLTS KKHSRKSSSY SSSSTTVKTS
- 
                                            Predicted Reactivity
- Dog: 93%, Guinea Pig: 86%, Human: 100%, Rat: 86%
- 
                                            Characteristics
- This is a rabbit polyclonal antibody against F2RL1. It was validated on Western Blot.
- 
                                            Purification
- Affinity Purified
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
- 
                                            Comment
- 
                        Antigen size: 397 AA 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handling Advice
- Avoid repeated freeze-thaw cycles.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
 
- 
                                            
- 
    - 
                                            : "Toward drugs for protease-activated receptor 2 (PAR2)."    in: Journal of medicinal chemistry, Vol. 56, Issue 19, pp. 7477-97, (2013)         (PubMed).        
 
 
- 
                                            : "Toward drugs for protease-activated receptor 2 (PAR2)."    in: Journal of medicinal chemistry, Vol. 56, Issue 19, pp. 7477-97, (2013)         (PubMed).        
- 
    - F2RL1 (Coagulation Factor II (thrombin) Receptor-Like 1 (F2RL1))
- 
                                            Alternative Name
- F2RL1
- 
                                            Background
- 
                        Coagulation factor II (thrombin) receptor-like 1 (F2RL1) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins. F2RL1 is also a member of the protease-activated receptor family. It is activated by trypsin, but not by thrombin. It is activated by proteolytic cleavage of its extracellular amino terminus. The new amino terminus functions as a tethered ligand and activates the receptor. The F2RL1 gene contains two exons and is widely expressed in human tissues. The predicted protein sequence is 83 % identical to the mouse receptor sequence. 
 Alias Symbols: GPR11, PAR2
 Protein Interaction Partner: BIRC5, COPS5, UBC, Cbl, ST14, GPRASP1, PRTN3, F2, PLG, ELANE, CTSG, CAPN2, CAPN1,
 Protein Size: 397
- 
                                            Molecular Weight
- 44 kDa
- 
                                            Gene ID
- 2150
- 
                                            NCBI Accession
- NM_005242, NP_005233
- 
                                            UniProt
- P55085
- 
                                            Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome
 Target
- 
                    
 
                                     
                                     
                                    